zirconium has been researched along with Carcinoma, Epidermoid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budde, M; Jurek, P; Kiefer, GE; Perk, LR; van Dongen, GA; Visser, GW; Vosjan, MJ | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; de Bree, R; Jauw, YW; Leemans, CR; Roos, JC; van Dongen, GA | 1 |
| Baclayon, M; de Bree, R; Heuveling, DA; Hoekstra, OS; Leemans, CR; Roos, WH; van Dongen, GA; Visser, GW; Wuite, GJ | 1 |
| Boellaard, R; Boerman, OC; Finn, R; Snow, GB; Stigter-van Walsum, M; van Dongen, GA; van Eerd, JE; Verel, I; Visser, GW; Vosjan, MJ | 1 |
| Boellaard, R; Boerman, OC; Lammertsma, AA; Snow, GB; van Dongen, GA; van Eerd, J; Verel, I; Visser, GW | 1 |
| Leemans, CR; Perk, LR; Stigter-van Walsum, M; Tijink, BM; van Dongen, GA; Visser, GW; Vosjan, MJ | 1 |
| Zalutsky, MR | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; Comans, EF; de Bree, R; Jauw, YW; Kummer, JA; Lammertsma, AA; Leemans, CR; Roos, JC; van Dongen, GA; Vosjan, MJ | 1 |
| Hiltbrand, E; Joliat, D; Popowski, Y; Rouzaud, M | 1 |
1 trial(s) available for zirconium and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Bone Marrow; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Female; Head and Neck Neoplasms; Humans; Isotope Labeling; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radioisotopes; Radiometry; Recombinant Fusion Proteins; Tissue Distribution; Zirconium | 2009 |
8 other study(ies) available for zirconium and Carcinoma, Epidermoid
| Article | Year |
|---|---|
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Chelating Agents; Deferoxamine; Female; Humans; Isothiocyanates; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Positron-Emission Tomography; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Zirconium | 2010 |
89Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results.
Topics: Albumins; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Female; Head and Neck Neoplasms; Lymphatic Metastasis; Particle Size; Positron-Emission Tomography; Rabbits; Radioisotopes; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Zirconium | 2011 |
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Glycoproteins; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunoconjugates; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Xenograft Model Antitumor Assays; Yttrium Radioisotopes; Zirconium | 2003 |
Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Head and Neck Neoplasms; Humans; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasm Transplantation; Organ Specificity; Phantoms, Imaging; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Yttrium Radioisotopes; Zirconium | 2003 |
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lutetium; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes; Zirconium | 2005 |
Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.
Topics: Antibodies, Monoclonal; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Isotope Labeling; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |
Open magnetic resonance imaging using titanium-zirconium needles: improved accuracy for interstitial brachytherapy implants?
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Brachytherapy; Carcinoma, Squamous Cell; Feasibility Studies; Female; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Needles; Ovarian Neoplasms; Phantoms, Imaging; Titanium; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Zirconium | 2000 |